Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aratana Therapeutics Inc    PETX

ARATANA THERAPEUTICS INC

(PETX)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/15/2019 03/18/2019 03/19/2019 03/20/2019 03/21/2019 Date
3.66(c) 3.8(c) 3.9(c) 4.03(c) 3.83(c) Last
436 620 275 724 372 447 327 757 211 306 Volume
-3.68% +3.83% +2.63% +3.33% -4.96% Change
More quotes
Financials (USD)
Sales 2019 34,9 M
EBIT 2019 -13,0 M
Net income 2019 -14,1 M
Finance 2019 28,4 M
Yield 2019 -
Sales 2020 70,4 M
EBIT 2020 14,8 M
Net income 2020 8,74 M
Finance 2020 29,7 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 37,92
EV / Sales2019 4,57x
EV / Sales2020 2,24x
Capitalization 188 M
More Financials
Company
Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule... 
Sector
Pharmaceuticals
Calendar
05/08Earnings Release
More about the company
Surperformance© ratings of Aratana Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARATANA THERAPEUTICS INC
03/15ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K..
AQ
03/13ARATANA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
03/12ARATANA : 4Q Earnings Snapshot
AQ
03/12ARATANA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
03/12ARATANA THERAPEUTICS : Reports Fourth Quarter and Full Year 2018 Financial Resul..
PR
02/13ARATANA THERAPEUTICS : to Participate at Upcoming Investment Conferences
PR
02/12ARATANA THERAPEUTICS : to Report Fourth Quarter and Full Year 2018 Financial Res..
PR
02/05ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Ev..
AQ
02/04ARATANA THERAPEUTICS : Appoints Rhonda Hellums Chief Financial Officer
PR
01/22ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financia..
AQ
More news
Analyst Recommendations on ARATANA THERAPEUTICS INC
More recommendations
Sector news : Veterinary Drugs
01:55aEISAI : starts phase 3 trials for second Alzheimer's drug after first's failure
RE
01:38aUPS eyes in-home health services with U.S. vaccine project
RE
03/21JOHNSON & JOHNSON : J&J to record $700 million charge related to abandoned drug ..
RE
03/21JOHNSON & JOHNSON : J&J to Impair Value of Investigational Antiviral Treatment A..
DJ
03/21CONATUS PHARMACEUTICALS : Shares Plummet After Emricasan Study Misses Primary En..
DJ
More sector news : Veterinary Drugs
Chart ARATANA THERAPEUTICS INC
Duration : Period :
Aratana Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARATANA THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 7,50 $
Spread / Average Target 96%
EPS Revisions
Managers
NameTitle
Craig A. Tooman President, Chief Executive Officer & Director
Wendy L. Yarno Non-Executive Chairman
Rhonda Hellums Chief Financial Officer & Treasurer
John W. Vander Vort Independent Director
Laura A. Brege Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ARATANA THERAPEUTICS INC-37.52%188
ZOETIS16.48%47 159
ELANCO ANIMAL HEALTH INC3.01%12 004
DECHRA PHARMACEUTICALS22.51%3 382
JINYU BIO-TECHNOLOGY CO LTD49.34%3 011
VIRBAC21.09%1 333